Clinical Trial Update: Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant [NA]

View source ↗

Summary

The completed clinical trial focuses on cognitive disability and quality of life in relapsing-remitting multiple sclerosis patients treated with an immunosuppre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Immunosuppressant

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Multiple Sclerosis, Relapsing-Remitting | NA | Status: COMPLETED